Lifeward, Inc. (NASDAQ: LFWD) is a medical technology company specializing in the design, development and commercialization of innovative patient monitoring and safety solutions. The company’s core offerings include advanced temperature management systems, fluid warming devices and integrated monitoring platforms tailored for use in hospitals, outpatient clinics and emergency medical services. Lifeward’s product portfolio emphasizes reliability, ease of use and compliance with rigorous regulatory standards, delivering tools that support clinicians in maintaining optimal patient outcomes during critical care procedures.
Among its flagship devices are the ThermoGuard™ series of precision temperature control units which employ closed-loop feedback mechanisms to ensure consistent normothermia in surgical and recovery settings. In addition, the company’s rapid-fluid warmer modules provide controlled warming of intravenous fluids and blood products, reducing the risk of perioperative hypothermia and associated complications. Lifeward also offers software-driven analytics suites that aggregate real-time patient data streams, enabling care teams to monitor vital signs, generate alerts and streamline workflow across multiple care locations.
Founded in 2003 and headquartered in San Diego, California, Lifeward has expanded its footprint to serve healthcare providers across North America, Europe and parts of Asia-Pacific. The company has established a network of distribution partners and service centers that facilitate product installation, training and technical support. Over the past decade, Lifeward has secured ISO 13485 certification and received regulatory clearance from the U.S. Food and Drug Administration, underscoring its commitment to quality and patient safety.
Under the leadership of CEO Mark T. Johnson and CFO Emily R. Davis, Lifeward continues to pursue strategic investments in research and development. The executive team, together with a board of directors comprised of industry veterans and medical professionals, guides the company’s efforts to bring next-generation monitoring and warming technologies to market. Lifeward’s management remains focused on expanding product applications, strengthening global partnerships and enhancing its manufacturing capabilities to meet growing clinical demands.
AI Generated. May Contain Errors.
Free LFWD Stock Alerts